The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Timing of initiation of defibrotide (DF) post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final data from an expanded-access protocol.
 
Stephan A. Grupp
Consulting or Advisory Role - Janssen; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Novartis
 
Paul G. Richardson
Consulting or Advisory Role - Genmab
Research Funding - Celgene; Millennium
 
Angela R. Smith
No Relationships to Disclose
 
Brandon Triplett
No Relationships to Disclose
 
Nancy A. Kernan
Research Funding - Gentium; NCI
 
Joseph Harry Antin
No Relationships to Disclose
 
Leslie Lehmann
No Relationships to Disclose
 
Sergio Giralt
Honoraria - Amgen; CELGENE; Jazz Pharmaceuticals; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Janssen; Jazz Pharmaceuticals; Sanofi; Takeda
Research Funding - Celgene (Inst); Celgene (Inst); Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Sanofi
 
Wei Liang
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Robin Hume
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
William Tappe
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Robert Soiffer
Consulting or Advisory Role - Gentium; Jazz Pharmaceuticals